scholarly article | Q13442814 |
P50 | author | James David Chappell | Q91489970 |
P2093 | author name string | Terence S Dermody | |
Takeshi Kobayashi | |||
Laura S Ooms | |||
Mine Ikizler | |||
P2860 | cites work | An improved reverse genetics system for influenza A virus generation and its implications for vaccine production | Q24537680 |
Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome | Q24655367 | ||
Development and Application of a Reverse Genetics System for Japanese Encephalitis Virus | Q27473506 | ||
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing) | Q27486833 | ||
Structure of Reovirus σ1 in Complex with Its Receptor Junctional Adhesion Molecule-A | Q27653146 | ||
Cloned Poliovirus Complementary DNA Is Infectious in Mammalian Cells | Q28264266 | ||
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation | Q29616267 | ||
Generation of influenza A viruses entirely from cloned cDNAs | Q29616768 | ||
Gene-specific inhibition of reovirus replication by RNA interference. | Q30356543 | ||
Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain | Q33396212 | ||
Identification of signals required for the insertion of heterologous genome segments into the reovirus genome | Q33672488 | ||
Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va | Q33707803 | ||
Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo | Q33834964 | ||
Rescue of influenza A virus from recombinant DNA. | Q33846053 | ||
Genome trimming: a unique strategy for replication control employed by Borna disease virus | Q33927300 | ||
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones | Q33975389 | ||
Reovirus core protein mu2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules. | Q34122036 | ||
Recombinant vesicular stomatitis viruses from DNA. | Q34337129 | ||
Reovirus σNS and μNS Proteins Form Cytoplasmic Inclusion Structures in the Absence of Viral Infection | Q34976721 | ||
Establishment of a Nipah virus rescue system | Q35102401 | ||
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus | Q36690054 | ||
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles | Q36826294 | ||
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics | Q36943931 | ||
Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs | Q37095192 | ||
Identification of functional domains in reovirus replication proteins muNS and mu2. | Q37127878 | ||
Reovirus nonstructural protein sigma1s is required for establishment of viremia and systemic dissemination | Q37414112 | ||
Reovirus-based therapy for cancer | Q37519640 | ||
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. | Q37626247 | ||
Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter | Q39548682 | ||
Nonrandom segregation of parental alleles in reovirus reassortants. | Q39876656 | ||
Increased ubiquitination and other covariant phenotypes attributed to a strain- and temperature-dependent defect of reovirus core protein mu2. | Q39991940 | ||
Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency | Q40062777 | ||
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. | Q40652106 | ||
Infectious rabies viruses from cloned cDNA. | Q40793123 | ||
Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening | Q40845786 | ||
"Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template | Q40901694 | ||
Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR. | Q41258412 | ||
A plasmid-based reverse genetics system for animal double-stranded RNA viruses. | Q42084718 | ||
Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector | Q42688349 | ||
Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. | Q43076644 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 194-200 | |
P577 | publication date | 2009-12-29 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | An improved reverse genetics system for mammalian orthoreoviruses | |
P478 | volume | 398 |
Q40197777 | A Point Mutation in the Rhesus Rotavirus VP4 Protein Generated through a Rotavirus Reverse Genetics System Attenuates Biliary Atresia in the Murine Model |
Q34438868 | A Post-entry Step in the Mammalian Orthoreovirus Replication Cycle Is a Determinant of Cell Tropism |
Q64938927 | A Reverse Genetics System for Cypovirus Based on a Bacmid Expressing T7 RNA Polymerase. |
Q39067799 | A plasmid-based reverse genetics system for mammalian orthoreoviruses driven by a plasmid-encoded T7 RNA polymerase |
Q39225705 | A reverse genetics system of African horse sickness virus reveals existence of primary replication. |
Q90715237 | A single mutation in the mammalian orthoreovirus S1 gene is responsible for increased interferon sensitivity in a virus mutant selected in Vero cells |
Q38712130 | African Swine Fever Virus NP868R Capping Enzyme Promotes Reovirus Rescue during Reverse Genetics by Promoting Reovirus Protein Expression, Virion Assembly, and RNA Incorporation into Infectious Virions |
Q39046931 | Amino acids 78 and 79 of Mammalian Orthoreovirus protein µNS are necessary for stress granule localization, core protein λ2 interaction, and de novo virus replication. |
Q41637190 | Amino acids substitutions in σ1 and μ1 outer capsid proteins of a Vero cell-adapted mammalian orthoreovirus are required for optimal virus binding and disassembly |
Q37644034 | An ITAM in a nonenveloped virus regulates activation of NF-κB, induction of beta interferon, and viral spread |
Q36193053 | An Inhibitory Motif on the 5'UTR of Several Rotavirus Genome Segments Affects Protein Expression and Reverse Genetics Strategies |
Q47144608 | An in-vitro transcription assay for development of Rotavirus VP7. |
Q34362314 | Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates |
Q92511012 | Cell Entry-Independent Role for the Reovirus μ1 Protein in Regulating Necroptosis and the Accumulation of Viral Gene Products |
Q39406121 | Cell entry-associated conformational changes in reovirus particles are controlled by host protease activity |
Q40055051 | Characterization of a replicating mammalian orthoreovirus with tetracysteine tagged μNS for live cell visualization of viral factories |
Q47234337 | Cleavage of the C-terminal fragment of reovirus μ1 is required for optimal infectivity |
Q36253330 | Comparative analysis of Reoviridae reverse genetics methods |
Q36373033 | Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system |
Q58089543 | Components of the reovirus capsid differentially contribute to stability |
Q38871517 | Conformational changes required for reovirus cell entry are sensitive to pH. |
Q27671651 | Crystal Structure of Reovirus Attachment Protein σ1 in Complex with Sialylated Oligosaccharides |
Q30155993 | Determinants of strain-specific differences in efficiency of reovirus entry |
Q50043303 | Differential delivery of genomic dsRNA causes reovirus strain-specific differences in IRF3 activation |
Q27321066 | Diminished reovirus capsid stability alters disease pathogenesis and littermate transmission |
Q92964740 | Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response |
Q34276415 | Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus |
Q33743895 | Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells. |
Q36956100 | Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1 |
Q36855368 | Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression |
Q40352768 | Entirely plasmid-based reverse genetics system for rotaviruses |
Q38832246 | Establishment of an entirely plasmid-based reverse genetics system for Bluetongue virus |
Q38744368 | Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus |
Q31137956 | Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells |
Q38721800 | Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus |
Q37123318 | Genetic determinants of reovirus pathogenesis in a murine model of respiratory infection |
Q35172332 | Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus |
Q91862894 | In Vivo Live Imaging of Oncolytic Mammalian Orthoreovirus Expressing NanoLuc Luciferase in Tumor Xenograft Mice |
Q49182824 | Infectious Subviral Particle to Membrane Penetration Active Particle (ISVP-to-ISVP*) Conversion Assay for Mammalian Orthoreovirus. |
Q54253762 | Infectious Subviral Particle-induced Hemolysis Assay for Mammalian Orthoreovirus. |
Q36928980 | Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry |
Q38809456 | Lipid Membranes Facilitate Conformational Changes Required for Reovirus Cell Entry. |
Q39163586 | Lipids Cooperate with the Reovirus Membrane Penetration Peptide to Facilitate Particle Uncoating |
Q36155563 | Mechanisms of reovirus bloodstream dissemination |
Q35868303 | Molecular determinants of proteolytic disassembly of the reovirus outer capsid. |
Q47547819 | Multiple proteins differing between laboratory stocks of mammalian orthoreoviruses affect both virus sensitivity to interferon and induction of interferon production during infection |
Q40458730 | Novel High-throughput Approach for Purification of Infectious Virions |
Q39312059 | Optimum length and flexibility of reovirus attachment protein σ1 are required for efficient viral infection |
Q26775033 | Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants |
Q57469919 | Protein Mismatches Caused by Reassortment Influence Functions of the Reovirus Capsid |
Q59352777 | Reovirus Neurotropism and Virulence Are Dictated by Sequences in the Head Domain of the Viral Attachment Protein |
Q36850813 | Reovirus activates a caspase-independent cell death pathway. |
Q40254093 | Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. |
Q39307482 | Reovirus replication protein μ2 influences cell tropism by promoting particle assembly within viral inclusions |
Q38743317 | Reovirus μ1 Protein Affects Infectivity by Altering Virus-Receptor Interactions. |
Q52668679 | Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection. |
Q38920004 | Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike |
Q35931526 | Reverse Genetics for Fusogenic Bat-Borne Orthoreovirus Associated with Acute Respiratory Tract Infections in Humans: Role of Outer Capsid Protein σC in Viral Replication and Pathogenesis |
Q40200095 | Reverse Genetics for Mammalian Orthoreovirus |
Q59350530 | Reverse Genetics for Peste des Petits Ruminants Virus: Current Status and Lessons to Learn from Other Non-segmented Negative-Sense RNA Viruses |
Q97564052 | Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design |
Q30405337 | Reverse genetics for mammalian reovirus |
Q41962337 | Reverse genetics of rotavirus |
Q92376467 | Rotavirus Species B Encodes a Functional Fusion-Associated Small Transmembrane Protein |
Q91760731 | Selection and Characterization of a Reovirus Mutant with Increased Thermostability |
Q32183285 | Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus. |
Q38321514 | Serotype-specific differences in inhibition of reovirus infectivity by human-milk glycans are determined by viral attachment protein σ1. |
Q27675479 | The GM2 Glycan Serves as a Functional Coreceptor for Serotype 1 Reovirus |
Q40088760 | The reovirus μ1 340-343 loop controls entry related conformational changes. |
Q36685206 | The sweet spot: defining virus-sialic acid interactions |
Q39088516 | The μ1 72-96 loop controls conformational transitions during reovirus cell entry. |
Q38700849 | Two-plasmid system to increase the rescue efficiency of paramyxoviruses by reverse genetics: The example of rescuing Newcastle Disease Virus |
Q41080969 | Viral gene expression potentiates reovirus-induced necrosis. |
Search more.